|
|
||||||||
expression follows microvascular loss in advanced murine adriamycin nephrosis
1The University of Sydney at Westmead Millennium Institute, Sydney, New South Wales, Australia; and 2Institute of Veterinary Physiology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland
Submitted 14 July 2003 ; accepted in final form 16 September 2004
Cellular hypoxia has been proposed as a major factor in the pathogenesis of chronic renal injury, yet to date there has been no direct evidence to support its importance. Therefore, we examined cortical hypoxia in an animal model of chronic renal injury (murine adriamycin nephrosis; AN) by assessing nuclear localization of the oxygen-dependent
-subunit of hypoxia-inducible factor-1 (HIF-1
) in animals 7, 14, and 28 days after adriamycin. Results were assessed in conjunction with quantitation of the cortical microvasculature (by CD34 immunostaining) and cortical expression of VEGF. Cortical apoptosis was also examined by terminal deoxynucleotidyl transferase dUTP nick-end labeling staining. A dramatic and significant increase in nuclear localization of HIF-1
was seen 28 days after adriamycin in the context of severe glomerular and tubulointerstitial damage. Areas of nuclear HIF-1
staining did not colocalize with areas of cellular apoptosis. AN was also associated with a significant attenuation of the peritubular capillaries that was significant at 14 and 28 days after adriamycin. Cortical VEGF expression fell in a stepwise manner from day 7 until day 28 after adriamycin. In conclusion, these data are consistent with a significant increase in cellular hypoxia occurring in the advanced stages of murine AN. Increased cortical hypoxia was preceded by significant reductions in both the number of peritubular capillaries (i.e., oxygen supply) and the angiogenic cytokine VEGF. Apart from providing the first direct evidence for cellular hypoxia in a model of chronic renal disease, these results suggest that a primary dysregulation of angiogenesis may be the cause of increased hypoxia in this model.
capillary; chronic; tubular
This article has been cited by other articles:
![]() |
J. Du, Y.-Y. Fan, H. Hitomi, H. Kiyomoto, S. Kimura, C.-Z. Kong, T. Noma, M. Kohno, A. Nishiyama, and D. Nakano Mineralocorticoid receptor blockade and calcium channel blockade have different renoprotective effects on glomerular and interstitial injury in rats Am J Physiol Renal Physiol, September 1, 2009; 297(3): F802 - F808. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. I. Levy, E. L. Schiffrin, J.-J. Mourad, D. Agostini, E. Vicaut, M. E. Safar, and H. A.J. Struijker-Boudier Impaired Tissue Perfusion: A Pathology Common to Hypertension, Obesity, and Diabetes Mellitus Circulation, August 26, 2008; 118(9): 968 - 976. [Full Text] [PDF] |
||||
![]() |
J. T. Norman Protecting the Microvasculature: A Tie-ght Connection to Ameliorating Chronic Kidney Disease? J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2353 - 2355. [Full Text] [PDF] |
||||
![]() |
T. Tanaka, H. Kato, I. Kojima, T. Ohse, D. Son, T. Tawakami, T. Yatagawa, R. Inagi, T. Fujita, and M. Nangaku Hypoxia and expression of hypoxia-inducible factor in the aging kidney. J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2006; 61(8): 795 - 805. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. H. Haase Hypoxia-inducible factors in the kidney Am J Physiol Renal Physiol, August 1, 2006; 291(2): F271 - F281. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nangaku Chronic Hypoxia and Tubulointerstitial Injury: A Final Common Pathway to End-Stage Renal Failure J. Am. Soc. Nephrol., January 1, 2006; 17(1): 17 - 25. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |